Legal Representation
Attorney
B. Michelle Alvey
USPTO Deadlines
Next Deadline
2158 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-10-07)
Due Date
October 07, 2031
Grace Period Ends
April 07, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 7, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 7, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 3, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 19, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 19, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 13, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 14, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 7, 2025 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jun 10, 2025 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| May 13, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 13, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 13, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 13, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 13, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 22, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 22, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 14, 2025 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Apr 8, 2025 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Mar 17, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 1, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Feb 10, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 8, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Feb 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 19, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Sep 13, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Aug 7, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 7, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 7, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 10, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 10, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 2, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 25, 2023 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
| Oct 6, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Oct 3, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Oct 2, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 14, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 12, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 7, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Unprocessed chemical products, namely, unprocessed plastics, unprocessed polymers, unprocessed artificial resins; biochemical catalysts, catalysts for chemical and biochemical processes, catalysts for use in the manufacture of industrial chemicals; chemical reagents for non-medical purposes; chemical additives for use in the manufacture of pharmaceuticals, agrochemicals, cosmetics, food products, and polymers; chemical products as chemical synthesis intermediates for industrial purposes; active chemical ingredients for use in manufacture of pharmaceuticals, agrochemicals, cosmetics, food products, and polymers; hemi synthesis products, namely, semi-synthesized chemical products for use in biotechnological product development; fertilizers; chemical products as intermediates for the production of pharmaceutical, veterinary, medical and cosmetic active ingredients
Class 003
Purified essential oil extracts, for industrial use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries
Class 005
Pharmaceutical, veterinary, sanitary products, namely, steroids, diuretic preparations, anti-inflammatory preparations, dietary supplements, nutritional supplements, diagnostic agents for medical purposes being visualization agents for use during colonoscopies, contraceptive preparations, preparations for the treatment of burns, pharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agent, pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; fungicides, herbicides, insecticides, and pesticides
Class 040
Contract manufacturing of pharmaceutical and chemicals and their components for third parties; contract manufacturing of pharmaceuticals, chemicals and biopharmaceuticals; custom manufacturing of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides, and other therapeutic biomolecules; custom manufacturing on a pilot and commercial scale of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides and other therapeutic biomolecules; custom manufacturing in the nature of processing of functional food and food ingredients; custom manufacturing in the nature of processing on pilot and commercial scale of functional food and food ingredients; custom manufacturing of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; custom manufacturing on a pilot and commercial scale of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; custom manufacturing of chemicals through chemical syntheses; processing of biochemicals through the synthesis of biological products for customers in the food, chemical, agricultural, veterinary and pharmaceutical industries; custom synthesis of intermediate products in the nature of intermediate organic products for industrial purposes for the food, chemical, agricultural, veterinary, and pharmaceutical industries; contract manufacturing of hazardous products being glycerol trinitrate, azides, explosives and other industrial chemicals for third parties; contract custom manufacturing of substitution aromates and chiral molecules for use in synthesis of products for others for third parties; preparation of galenic formulations for others, namely, custom manufacture of pharmaceuticals by pharmaceutical compounders
Class 042
Providing quality control, namely, analytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing products, notably for the food, chemical, agricultural, veterinary, pharmaceutical industries; scientific research in the field of galenic forms, specifically for others
Additional Information
Design Mark
The mark consists of a stylized letter "A" comprised of a petrol-green circle to the left of a green curved triangle, all stacked above a wide yellow-green semi-circle to the left of a purple semi-circle. All instances of the color white represent background, outlining, shading, and/or transparent area and is not part of the mark.
Color Claim
The color(s) green, purple, yellow-green and petrol-green is/are claimed as a feature of the mark.
Classification
International Classes
001
003
005
040
042